Proposal of Intergenerational Tobacco Ban in Indiana Senate Bill

Feb.08

Indiana Senator Ed Charbonneau introduced a bill proposing a tobacco ban for those born after June 30, 2004.

According to a report from Halfwheel on January 14th, Indiana State Senator Ed Charbonneau has introduced a bill proposing a ban on tobacco products for the younger generation. If the bill is passed, it would mean that individuals born after June 30, 2004 would not be able to purchase tobacco products, e-cigarettes, or e-liquid in the state.

Senate Bill 322 would also ban individuals born after June 30, 2004 from ordering tobacco products and having them shipped within the state. Businesses would be required to use shipping services that can verify the recipient's age. If approved, the ban would take effect on July 1. The bill has been submitted to the State Senate Health and Providers Committee for consideration and is awaiting its first round of debate.

In recent years, several regions have proposed intergenerational tobacco bans. Hawaii considered such a bill in 2023 but did not implement it. Some lawmakers in Massachusetts plan to introduce a similar bill in 2025 to impose the same ban as the one in Brookline, a ban that was upheld by the state's highest court.

However, there have been opposition and retreat in some places. New Zealand, as the first country in the world to implement such a ban, repealed the ban in early 2024. In addition, the city of Pittsfield in Massachusetts suspended the ban's progress in October due to opposition. Over the past year, several other cities in Massachusetts have also announced plans to explore the ban.

The Cigar Rights of America (CRA) has expressed opposition to the proposal, stating that such a ban would lead to the rise of the black market and economic instability. The organization has launched an online form that can be used to contact legislators to express opposition to the bill.

References:

[1] Generational Tobacco Ban Proposed in Indiana

Also Read:

[1] Rising Trend of E-cigarette Usage in Indiana

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

Bulgaria to Increase Tobacco and Nicotine Product Taxes in 2026, Expected to Generate Additional Revenue of 130 Million Euros

Bulgaria will raise excise taxes on cigarettes, cigars, heated tobacco, and e-cigarette liquids starting January 2026. The increase, approved under the 2026 state budget, will be implemented gradually over four years. The Ministry of Finance expects the reform to generate about €130 million in additional revenue by 2026.

Nov.07 by 2FIRSTS.ai

South Korea’s Parliament Reconsiders Bill to Regulate Synthetic Nicotine as Tobacco

South Korea’s National Assembly is once again reviewing a bill to classify synthetic nicotine as a tobacco product under the Tobacco Business Act. The proposal aims to close regulatory loopholes that allow untaxed, unregulated nicotine liquids — often used by minors — to circulate freely. Lawmakers expect the bill to pass during the current session amid growing public and civic pressure.

Nov.26 by 2FIRSTS.ai

Heaven Gifts’s HNB Brand REJO Launches New Device with Design Strikingly Similar to ELFBAR JOINOne Series

Miracle’s heated tobacco brand REJO has launched its new device REJO CUBE in Dubai. The device’s industrial design is highly similar to the ELFBAR JOINOne series, featuring a left-right magnetic structure and side-mounted screen. Positioning the Middle East as a key market, REJO is moving ahead with local team building and entity setup in the region.